Alex Agnoletto is the founder of Juniper Biosciences. Juniper Biosciences has raised $40M in total funding. Latest round: Seed. Based in Bridgewater, NJ, USA.
Alex Agnoletto is the CEO of Juniper Biosciences, an innovative radiopharmaceutical drug development company. The company recently raised an oversubscribed and upsized $40 million seed financing round. Prior to Juniper Biosciences, Agnoletto served as the CFO of Evergreen Theragnostics.
Full founder directory · Investor directory · Company funding database · Fundraising library